Biotech

All Articles

J &amp J falls phase 2 dengue candidate in most recent shift from vaccinations

.Johnson &amp Johnson's deprioritization of its infectious condition pipe has actually stated an add...

Relay loses 10% of staff after earlier discharges in July

.Preciseness medicine biotech Relay Rehabs is shedding approximately 10% of its workforce in attempt...

Pentixapharm credit ratings $22M IPO to accommodation radiopharma tests

.Pentixapharm has generated practically twenty thousand europeans ($ 22 million) from an IPO, along ...

Lundbeck water faucets Charles Stream for AI-enabled neuro drug breakthrough

.Lundbeck has actually used Charles Stream Laboratories' expert system capabilities to assist the br...

Big pharma, biotech 'won't necessarily be symbiotic' in artificial intelligence: S&ampP

.Large Pharma is actually putting in highly in artificial intelligence to reduce growth timetables a...

I &amp I biotech Triveni elevates $115M for preclinical antitoxins

.Triveni Bio has roped in $115 thousand in series B funds to accelerate preclinical antitoxin course...

IGM turns coming from cancer cells to autoimmune, shaking up C-suite

.IGM Biosciences ended in 2014 giving up personnel and simplifying its own cancer cells pipe. Curren...

Shattuck axes CD47 program over unstable efficacy information, lays off 40% of personnel and loses Ono handle

.Shattuck Labs has pounded an additional nail in to the coffin of CD47. After seeing a "modest" resu...

BioMarin goes Camping outdoors, striking RNA manage biotech

.BioMarin is including kindling to the R&ampD fire, blowing a complement with CAMP4 Rehabs for right...

Cash- strapped Gritstone starts hunt for key choices as cancer vaccine records underwhelm

.Gritstone biography has actually produced banks to look into "prospective value-maximizing techniqu...